Education
About Us
Working with TipRanks
Follow Us
Elevation Oncology, Inc. (ELEV)
:ELEV
ELEV Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Elevation Oncology News
ELEV FAQ
What was Elevation Oncology, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Elevation Oncology, Inc.’s market cap?
Currently, no data Available
When is Elevation Oncology, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Elevation Oncology, Inc.’s earnings last quarter?
Currently, no data Available
Is Elevation Oncology, Inc. overvalued?
According to Wall Street analysts Elevation Oncology, Inc.’s price is currently Undervalued.
Does Elevation Oncology, Inc. pay dividends?
Elevation Oncology, Inc. does not currently pay dividends.
What is Elevation Oncology, Inc.’s EPS estimate?
Elevation Oncology, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elevation Oncology, Inc. have?
Currently, no data Available
What happened to Elevation Oncology, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Elevation Oncology, Inc.?
Currently, no hedge funds are holding shares in ELEV
Company Description
Elevation Oncology, Inc.
Elevation Oncology (ELEV) is a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer. The company operates in the biotechnology and pharmaceuticals sectors, with a core focus on identifying and developing therapies that target unique genetic drivers of cancer. Elevation Oncology aims to address unmet medical needs by advancing a pipeline of targeted therapies designed to improve patient outcomes in oncology.
Elevation Oncology (ELEV) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
MEI Pharma
―
GeoVax Labs
―
Cellectar Biosciences
―
Akari Therapeutics
―
Sol-Gel Technologies
―
Ownership Overview
―
Insiders
6.15%
Mutual Funds
― Other Institutional Investors
93.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---